herenciageneticayenfermedad: Parkinson's Disease

miércoles, 7 de febrero de 2018

Parkinson's Disease - Feb 6, 2018 Edition

Health News and Information - News Medical

	February 6, 2018
	Parkinson's Disease
	The latest Parkinson's disease news from News Medical

Conformation-SpecificAlpha-Synuclein Antibody for Research into Parkinson’s Disease

In the brains of patients suffering from Parkinson's disease, misfolding and aggregation of native alpha-synuclein occurs, resulting in the formation of filamentous Lewy bodies. Aggregated alpha-synuclein can be detected by anti-alpha synuclein filament antibody (ab209530), which is a conformation-specific antibody.

			Scientists test new tactic for controlling motor complications in Parkinson's disease Standard drug treatment for Parkinson's disease can over time induce motor complications that reduce the effectiveness of restoring mobility.

			UK-based charity to accelerate development of promising new drug for Parkinson's UK-based charity, Parkinson's UK is set to provide more than $1million in funding to US biotech company, Neurolixis, to accelerate the development of a promising new drug for people with Parkinson's.

	Researchers explore new biomarkers for early detection of Parkinson’s from speech The study of new non-invasive biomarkers able to identify the Parkinson's disease from the speech of patients is the joint work carried out by researchers from Universidad Politécnica de Madrid, Massachusetts Institute of Technology and Johns Hopkins University.

	Harvard scientists identify molecular machinery responsible for dopamine release in the brain Studied for decades for its critical role in movement control and reward-seeking behaviors, the neurotransmitter dopamine has been the focus of numerous efforts to understand its activity, particularly when it goes awry in disorders such as Parkinson's and addiction.